register

Leadership & Management

Immediate actions to assess organisational exposure to coronavirus

Health Industry Hub | March 16, 2020 |
[Total: 1    Average: 4/5]

The rapid outbreak of the coronavirus presents an alarming health crisis that the world is coming to terms with. In addition to the human impact, there is also a significant commercial impact being felt globally.

What are the immediate actions to consider?

Protect your people and customers

  • Leverage Human Resources and Management expertise to maintain employees’ physical and mental well-being, providing guidance to employees and reassessing travel policies.
  • Exercise best-in-practice corporate social responsibility regarding employee stability, wider society and economy and pursuing ways to support response efforts.
  • Encourage employees to work remotely and have virtual meetings.
  • If the office or a worksite needs to be temporarily closed, take care to ensure employees understand corporate policies surrounding pay and benefits.
  • Leverage external digital solutions to communicate with healthcare professionals and other key stakeholders from a corporate and brand perspective.

Register FREE and join 20,000+ industry professionals who receive the latest industry news, innovations and insights from Health Industry Hub; the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industries and its key stakeholders.

Assess supplier risk

  • Create a crisis response team to facilitate the open and consistent flow of digitally delivered information to key stakeholders, maintaining stakeholder confidence and informing customers who will be impacted.
  • Establish a team to focus on supply chain assessment and risk management.
  • Map urgency of sourced materials to high-value products and revenue streams.
  • Review contracts with key stakeholders to understand liability in the event of supply shortage.
  • Determine exposure by identifying current and buffer inventory, building tier-transparency and short-term action plans.
  • Conduct a value chain assessment of other risk factors that may escalate costs, for example transportation shortages, taking proactive action to address anticipated shortages.

Manage business plans

  • Revise cash flow, working capital management and inventory forecasts alongside supply and demand predictions.
  • Understand how financial stability may be impacted from further stock market declines and restrictions in access to funding.
  • Review organisation-wide business plans to ensure all business functions are aligned.

To assist your team in achieving your best results while reducing the coronavirus risk, we combine our expertise in delivering and measuring digital content, with 20+ years industry experience. Learn more about how we can help you to deliver educational content digitally to HCPs.


Medical

Medical Pharma Biotech MedTech - Achieving gender equity for female researchers - Professor Julie Campbell, GSK award winner

Achieving gender equity for female researchers – Professor Julie Campbell, GSK award winner

Health Industry Hub | August 6, 2021 |

Medical News: GSK Australia Award for Research Excellence (ARE) is one of the most prestigious and long-standing awards available to […]

More


News & Trends - Medical Technology

MedTech News - Baxter Healthcare launches on-site pop-up COVID vaccination clinic

Baxter launches on-site pop-up COVID vaccination clinic

Health Industry Hub | August 6, 2021 |

MedTech News: Baxter Healthcare has launched an on-site pop-up vaccination clinic at its Western Sydney site this week to support […]

More


News & Trends - Pharmaceuticals

Pharma News - Cancer treatments minimally impacted during COVID-19 lockdowns in Australia, new study

Cancer treatments minimally impacted during COVID-19 lockdowns in Australia, new study

Health Industry Hub | August 6, 2021 |

Pharma News: Australian cancer patients kept up their pharmaceutical treatments during last year’s COVID-19 lockdowns, a big data study from […]

More


News & Trends - Pharmaceuticals

Pharma News - Could PARP inhibitors benefit more ovarian cancer patients?

Could PARP inhibitors benefit more ovarian cancer patients?

Health Industry Hub | August 6, 2021 |

Pharma News: Researchers have made a discovery that could help more Australian women with ovarian cancer gain access to game-changing […]

More